Clinical Trials Sponsored by Attune Hearing

Total 1101 results

Consciousness and Healing Initiative

Not yet recruiting

Sound Healing for Anxiety: A Randomized Controlled Trial

Anxiety | Anxiety State | Mental Health Issue | Anxiety Generalized
Ferring Pharmaceuticals
Ferring Pharmaceuticals Korea, Ltd.

Completed

Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate Cancer

Prostate Cancer

Korea, Republic of
Children's Hearing Evaluation and Amplification...

Unknown

An 'Off-the-shelf' Assistive Listening Device: Normal-hearing Children.

Auditory Processing Disorder

United Kingdom
Ferring Pharmaceuticals
Ferring Pharmaceuticals Korea, Ltd.

Completed

Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients

Prostate Cancer

Korea, Republic of
CSL Behring

Not yet recruiting

Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy

Hemophilia B
Ferring Pharmaceuticals

Recruiting

A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China (COCO)

Infertility, Female

China
Ferring Pharmaceuticals

Recruiting

ADSTILADRIN Early Utilization and Outcomes in the Real World Setting in the United States (ABLE-41)

Bladder Cancer

United States
CSL Behring

Recruiting

An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B (IX-TEND 4001)

Hemophilia B

United States
CSL Behring

Recruiting

First-In-Human Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Escalating Single And Multiple Doses Of CSL040 In Healthy Subjects

Complement Deficiencies

Australia
Ferring Pharmaceuticals

Recruiting

REBYOTA™ Prospective Registry (ROAR)

Recurrence of Clostridium Difficile Infection

United States
Ferring Pharmaceuticals

Recruiting

Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With High-grade, BCG Unresponsive, Non-muscle Invasive Bladder Cancer (NMIBC)

Bladder Cancer

Japan
CSL Behring

Recruiting

Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study )

Traumatic Injury

United States, United Kingdom, Australia
Ferring Pharmaceuticals

Recruiting

Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy (PICCOLO)

Bowel Preparation

United States
CSL Behring

Active, not recruiting

Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks

Hereditary Angioedema

Australia, Canada, United States, New Zealand, Germany, Hong Kong, Netherlands, Taiwan, Czechia, Israel, Hungary, Japan, Russian Federation, Spain
Ferring Pharmaceuticals

Completed

Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease (PROGNOS)

Crohn's Disease

Germany
CSL Behring

Active, not recruiting

Register of Patients With haEmophilia A tReated With Afstyla® (OPERA)

Haemophilia A

France
CSL Behring

Completed

CSL312 Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

United States, Canada, United Kingdom, Australia, Germany, Poland, Belgium, Austria, Denmark, Italy, Spain
Ferring Pharmaceuticals

Terminated

Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely (MERMAID)

Preterm Delivery | Inadequate Milk Production

United States
CSL Behring

Completed

Safety and Pharmacokinetics of IgPro20 and IgPro10 in Adults With Systemic Sclerosis (SSc)

Diffuse Cutaneous Systemic Sclerosis

Australia, Germany, Poland, Italy, United Kingdom
Ferring Pharmaceuticals

Completed

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in India Women (IRIS)

Infertility

India
CSL Behring

Completed

Dose Confirmation Trial of AAV5-hFIXco-Padua

Hemophilia B

United States
Ferring Pharmaceuticals

Completed

Post-Marketing Surveillance (PMS) Protocol of REKOVELLE Pre-Filled Pen (Follitropin Delta)

Infertility, Female

Korea, Republic of
Ferring Pharmaceuticals

Completed

The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancer

Prostate Cancer

United Kingdom
Ferring Pharmaceuticals

Completed

Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia) (NOC01)

Nocturia Due to Nocturnal Polyuria

Japan
Ferring Pharmaceuticals

Completed

MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population (MEGASET HR)

Infertility

United States
CSL Behring

Completed

Safety of Single Doses of CSL889 in Adult Patients With Sickle Cell Disease

Sickle Cell Disease

United States, United Kingdom, Netherlands
Ferring Pharmaceuticals

Completed

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2 (ESTHER-2)

Infertility

Canada, Belgium, Brazil, Czechia, Denmark, France, Italy, Poland, Russian Federation, Spain, United Kingdom
Ferring Pharmaceuticals

Completed

A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation. (RAINBOW)

Controlled Ovarian Stimulation

United Kingdom, Denmark, Belgium, Czechia, Spain
Ferring Pharmaceuticals

Completed

Quinagolide Vaginal Ring on Lesion Reduction Assessed by MRI in Women With Endometriosis/Adenomyosis (QLARITY)

Endometriosis

Germany, Poland, Denmark, Italy
Ferring Pharmaceuticals

Completed

An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancer (PandaExtension)

Prostate Cancer

China
CSL Behring

Completed

Safety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects With Hidradenitis Suppurativa and Palmoplantar Pustulosis

Hidradenitis Suppurativa | Palmoplantar Pustulosis

Denmark, Australia, Germany
Ferring Pharmaceuticals

Completed

General Drug Use-results Survey on PROPESS Vaginal Inserts in Treatment for Initiation of Cervical Ripening in Patients at Term (From 37 Completed Weeks of Gestation)

Pregnancy | Cervical Ripening

Japan
Ferring Pharmaceuticals

Completed

A Cross-Functional, Population-Representative, Web-Based, Epidemiologic Study to Estimate the Prevalence and Burden of Nocturia Due to Nocturnal Polyuria in the US

Nocturnal Polyuria

United States
Ferring Pharmaceuticals

Completed

Study to Assess the Patterns of Use of REKOVELLE® in Naïve Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures (PROFILE)

Controlled Ovarian Stimulation

Australia, Austria, Belgium, Canada, Germany, Italy, Netherlands, Poland, Spain, United Kingdom
CSL Behring

Completed

A Study to Compare the Pharmacokinetics of CSL312 Administered by Prefilled Syringe Assembled to Autoinjector to the Pharmacokinetics Administered by Prefilled Syringe Assembled to Needle Safety Device in Healthy Subjects

Healthy Participants

United States
Ferring Pharmaceuticals

Completed

Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND) (BEYOND)

Infertility, Female

Norway, Israel, Denmark, Netherlands, Italy, Austria, Switzerland
Ferring Pharmaceuticals

Completed

A Study Comparing MENOPUR in a Pen Formulation With a Powder and Solvent Formulation in Healthy Women

Infertility, Female

China
Ferring Pharmaceuticals

Completed

MEDAM (Menopur Retrospective Data prograM) (MEDAM)

Infertility, Female

France
Ferring Pharmaceuticals

Completed

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1 (ESTHER-1)

Infertility

Canada, Belgium, Brazil, Czechia, Denmark, France, Italy, Poland, Russian Federation, Spain, United Kingdom
CSL Behring

Terminated

Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects

Coronavirus Disease 2019 (COVID-19)

Australia
CSL Behring

Terminated

CSL200 Gene Therapy in Adults With Severe Sickle Cell Disease

Anemia, Sickle Cell

United States
CSL Behring

Completed

Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

Italy, United States, France, Argentina, Mexico, Japan, Canada, Hungary, South Africa
CSL Behring

Terminated

Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects

Oral Mucositis

United States, Canada, Australia, Germany, Italy, Austria
Ferring Pharmaceuticals

Terminated

Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial (SEPSIS-ACT)

Septic Shock

United States, Belgium, Denmark, France, Netherlands
Ferring Pharmaceuticals

Completed

Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)

Ulcerative Colitis

Switzerland, Russian Federation, Latvia, United States, Hungary, Ukraine, Bulgaria, Canada, Mexico, Poland, Serbia
CSL Behring

Terminated

Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD) (ALD518-010)

Acute GvHD

United States
CSL Behring

Completed

A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

Hereditary Angioedema Types I and II

United States, Spain, Australia, Canada, Czechia, Hungary, Israel, Italy, Romania, United Kingdom
Herning Hospital

Completed

Detection of Adenomas in Screening Colonoscopy

Adenoma Colon

Denmark
Ferring Pharmaceuticals

Completed

Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology Procedures (SARA)

Progesterone Supplementation in Women Undergoing ART

United States
CSL Behring

Withdrawn

Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc)

Diffuse Cutaneous Systemic Sclerosis

Belgium, United States, Italy, Spain, France, Germany, United Kingdom, Argentina, Australia, Canada, Mexico, Poland, Switzerland

3

Subscribe